HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
(5R)-3-[3-fluoro-4-(3-hydroxyazetidin-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one → 3-(3-Fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(r)-(isoxazol-3-yloxymethyl)oxazolidin-2-one
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | (5R)-3-[3-fluoro-4-(3-hydroxyazetidin-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one | HCID 497421 | — |
| Edukt | (5R)-3-(3-Fluoro-4-(2-methylimidazol-1-yl)phenyl)-5-hydroxymethyloxazolidin-2-one | HCID 21356557 | — |
| Produkt | 3-(3-Fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(r)-(isoxazol-3-yloxymethyl)oxazolidin-2-one | HCID 69983189 | — |
Reaktionsschritte
Using essentially the same procedure as for the intermediate of Example 65, but starting with 3-(3-fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(R)-hydroxymethyloxazolidin-2-one (202 mg, 0.69 mmol), and purifying by chromatography on a 10 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 2.5% MeOH in dichloromethane, the title compound was prepared (137 mg).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US06617339B1 |
| Quelldatensatz | uspto-grants-2003_09 |
| ORD ID | ord-ad97199a624f4a19942add03c6b27245 |
| Quellennotiz | uspto-grants-2003_09 |